Consun Pharmaceutical Group Limited (“Consun”) (Stock Code: 1681) was successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited on 19 December 2013.

Consun is an integrated pharmaceutical company principally engaged in the research, manufacturing and sale of modern Chinese medicines and medical contrast medium in the PRC.

In this listing, we acted as the legal advisers to Consun with respect to Hong Kong laws.